Asiri Surgical Hospital Plc (AMSL.N0000) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With ROE of 9.44%, it has a very attractive valuation with a 0.00 Price to Book Value

Over the past year, while the stock has generated a return of 22.02%, its profits have risen by 4.6%

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

LKR Million (Small Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.36

Return on Equity

11.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

1,900 Million

(Quarterly Results - Jun 2025)

Net Profit:

202 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-5.0%

6 Months

10.83%

1 Year

22.02%

2 Years

6.4%

3 Years

1.53%

4 Years

-23.56%

5 Years

-11.33%

Asiri Surgical Hospital Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

15.98%

EBIT Growth (5y)

25.17%

EBIT to Interest (avg)

2.82

Debt to EBITDA (avg)

2.27

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.68

Tax Ratio

42.62%

Dividend Payout Ratio

59.68%

Pledged Shares

Institutional Holding

ROCE (avg)

11.43%

ROE (avg)

14.69%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

2.40

EV to EBITDA

1.90

EV to Capital Employed

0.27

EV to Sales

0.36

PEG Ratio

Dividend Yield

ROCE (Latest)

11.06%

ROE (Latest)

9.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 3.74% vs 1.40% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -5.20% vs 114.04% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,899.50",
          "val2": "1,831.10",
          "chgp": "3.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "409.50",
          "val2": "355.50",
          "chgp": "15.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "68.90",
          "val2": "77.30",
          "chgp": "-10.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "202.30",
          "val2": "213.40",
          "chgp": "-5.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "162.00%",
          "val2": "194.10%",
          "chgp": "-3.21%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.41% vs 17.48% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -8.54% vs 16.61% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,176.30",
          "val2": "6,619.70",
          "chgp": "8.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,399.70",
          "val2": "1,469.80",
          "chgp": "-4.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "335.00",
          "val2": "618.70",
          "chgp": "-45.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "682.60",
          "val2": "746.30",
          "chgp": "-8.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.80%",
          "val2": "159.80%",
          "chgp": "-1.90%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

1,899.50

1,831.10

3.74%

Operating Profit (PBDIT) excl Other Income

409.50

355.50

15.19%

Interest

68.90

77.30

-10.87%

Exceptional Items

0.00

Consolidate Net Profit

202.30

213.40

-5.20%

Operating Profit Margin (Excl OI)

162.00%

194.10%

-3.21%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 3.74% vs 1.40% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -5.20% vs 114.04% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

7,176.30

6,619.70

8.41%

Operating Profit (PBDIT) excl Other Income

1,399.70

1,469.80

-4.77%

Interest

335.00

618.70

-45.85%

Exceptional Items

0.00

Consolidate Net Profit

682.60

746.30

-8.54%

Operating Profit Margin (Excl OI)

140.80%

159.80%

-1.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 8.41% vs 17.48% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -8.54% vs 16.61% in Mar 2024

All Annual Results

Company CV

About Asiri Surgical Hospital Plc

Asiri Surgical Hospital Plc

Hospital

Asiri Surgical Hospital PLC is a provider of healthcare and hospital services. The Company is principally engaged in operating a two-tier hospital. The Company's hospital surgical services include general surgery; plastic surgery; cardiology; ear, nose, and throat (ENT) surgery; oncology, and orthopedics. Its hospital provides facilities, such as emergency treatment unit (ETU), positron emission tomography-computed tomography (PET-CT) scanner, physiotherapy and rehabilitation unit, dental unit, blood transfusion service, one-five Tesla multifunctional magnetic resonance imaging (MRI) scanning system, nine-bed intensive care unit (ICU), 64 slice/second spiral computed tomography (CT) scanner, four-dimensional (4D) real time ultrasound scanning system, digital x-ray system, mammography system, electroencephalogram/electromyography (EEG/EMG), chemotherapy ward and stem-cell unit. Asiri Hospital Holdings PLC is the Company's parent company.

Company Coordinates

Company Details

No 21, Kirimandala Mawatha, Colombo 5 , COLOMBO None : 5

Tel: 94 11 4524400

http://www.asirihospitals.com/asiri-group/our-locations/asiri-surgical-hospital-plc

Registrar Details